0.804
price down icon0.74%   -0.006
after-market Handel nachbörslich: .76 -0.044 -5.47%
loading
Schlusskurs vom Vortag:
$0.81
Offen:
$0.8257
24-Stunden-Volumen:
115.36K
Relative Volume:
0.15
Marktkapitalisierung:
$9.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.63%
1M Leistung:
+8.06%
6M Leistung:
-91.04%
1J Leistung:
-99.52%
1-Tages-Spanne:
Value
$0.7812
$0.84
1-Wochen-Bereich:
Value
$0.76
$0.8649
52-Wochen-Spanne:
Value
$0.375
$215.31

AEON Biopharma Inc. Stock (AEON) Company Profile

Name
Firmenname
AEON Biopharma Inc.
Name
Telefon
(949) 354-6499
Name
Adresse
5 Park Plaza, Suite 1750, Irvine
Name
Mitarbeiter
9
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
AEON's Discussions on Twitter

Vergleichen Sie AEON mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AEON
AEON Biopharma Inc.
0.804 9.03M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-08-18 Eingeleitet H.C. Wainwright Buy

AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten

pulisher
Jul 22, 2025

What drives AEON Biopharma Inc. stock priceSuperior stock selection - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Is AEON Biopharma Inc. a good long term investmentHigh-yield capital appreciation - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

AEON Biopharma Inc. Stock Analysis and ForecastRapid growth opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

why aeon biopharma inc. stock attracts strong analyst attentionFree Investment Community - Newser

Jul 22, 2025
pulisher
Jul 19, 2025

What analysts say about AEON Biopharma Inc. stockDynamic portfolio growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 15, 2025

what makes aeon biopharma inc. stock price move sharplyROI Focused Stock Calls - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why AEON Biopharma Inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes AEON Biopharma Inc. stock price move sharplyFree Access to Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How AEON Biopharma Inc. stock performs during market volatilitySmart Return Focused Trading - Newser

Jul 15, 2025
pulisher
Jun 18, 2025

AEON Biopharma (NASDAQ:AEON) Trading Down 10.2% – Should You Sell? - Defense World

Jun 18, 2025
pulisher
Jun 13, 2025

AEON Biopharma Holds Annual Stockholders Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

AEON Biopharma, Inc. (NASDAQ:AEON) Short Interest Update - Defense World

Jun 12, 2025
pulisher
May 27, 2025

AEON Biopharma Soars 13.67% on CEO Appointment, Talent Grants - AInvest

May 27, 2025
pulisher
May 24, 2025

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times

May 24, 2025
pulisher
May 23, 2025

AEON Biopharma Expands Team with 100K+ Stock Awards: Inside the Biotech's Latest Hiring Move - Stock Titan

May 23, 2025
pulisher
May 21, 2025

Aeon Biopharma Reports Positive Q1 2025 Earnings - TipRanks

May 21, 2025
pulisher
May 20, 2025

AEON Biopharma Releases New Corporate Presentation - TipRanks

May 20, 2025
pulisher
May 19, 2025

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025 - The Manila Times

May 19, 2025
pulisher
May 19, 2025

AEON Biopharma to Present Corporate Overview at Aegis Capital Corp. 2025 Virtual Conference - Nasdaq

May 19, 2025
pulisher
May 19, 2025

AEON Biopharma Unveils Next-Gen Botulinum Toxin Therapies: CEO Details Multi-Indication Pipeline - Stock Titan

May 19, 2025
pulisher
May 14, 2025

AEON Biopharma Advances Biosimilar Product Development and Appoints New CEO - Nasdaq

May 14, 2025
pulisher
May 14, 2025

AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times

May 14, 2025
pulisher
May 14, 2025

New AEON CEO Targets $3.3B Botox Market with FDA-Ready Biosimilar Development Plan - Stock Titan

May 14, 2025
pulisher
May 11, 2025

AEON Biopharma (AEON) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 09, 2025

Closing Bell Recap: AEON Biopharma Inc (AEON) Ends at 0.75, Reflecting a -11.76 Downturn - DWinneX

May 09, 2025
pulisher
May 06, 2025

AEON Biopharma Inc (AMEX: AEON) Stock: Investors Need To Know This - Stocksregister

May 06, 2025
pulisher
May 05, 2025

Is AEON Biopharma Inc’s (AMEX:AEON) Stock On The Decline? - Stocksregister

May 05, 2025
pulisher
Apr 26, 2025

AEON Biopharma gets NYSE American nod for compliance plan - Investing.com Australia

Apr 26, 2025
pulisher
Apr 25, 2025

AEON Biopharma gets NYSE American nod for compliance plan By Investing.com - Investing.com Canada

Apr 25, 2025
pulisher
Apr 25, 2025

AEON Biopharma Says NYSE American Accepts Plan to Regain Compliance - marketscreener.com

Apr 25, 2025
pulisher
Apr 25, 2025

AEON Biopharma Receives Acceptance from NYSE American to Regain Compliance with Listing Standards - Nasdaq

Apr 25, 2025
pulisher
Apr 25, 2025

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

NYSE American Grants AEON Biopharma 2-Year Lifeline to Meet Listing Requirements - Stock Titan

Apr 25, 2025
pulisher
Apr 25, 2025

AEON Biopharma’s Fight to Stay Listed: A High-Stakes Gamble? - AInvest

Apr 25, 2025
pulisher
Apr 24, 2025

What was AEON Biopharma Inc (AEON)’s performance in the last session? - uspostnews.com

Apr 24, 2025

Finanzdaten der AEON Biopharma Inc.-Aktie (AEON)

Es liegen keine Finanzdaten für AEON Biopharma Inc. (AEON) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):